The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1365-2125.2004.02257.XPMID 15752375PMCID PMC1884785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.

  2002cited by this paper
• Automated solid-phase extraction for determination of amodiaquine, chloroquine and metabolites in capillary blood on sampling paper by liquid chromatography

  2002cited by this paper
• Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots.

  2001cited by this paper
• Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteers.

  1993cited by this paper
• The disposition of amodiaquine in Zambians and Nigerians with malaria.

  1990cited by this paper
• The disposition of amodiaquine in man after oral administration.

  1987cited by this paper
• Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans.

  1985cited by this paper
• A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea.

  1966cited by this paper

• Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022

  2025cites this paper
• Malaria control and elimination in Vanuatu and Papua New Guinea: Multidisciplinary and collaborative research with island communities, 1985-2024.

  2025cites this paper
• An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria

  2022cites this paper
• Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria

  2021influential citation
• In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018

  2021cites this paper
• The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data

  2020cites this paper
• A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine

  2019cites this paper
• Population Pharmacokinetic Estimates Suggest Elevated Clearance and Distribution Volume of Desethylamodiaquine in Pediatric Patients with Sickle Cell Disease Treated with Artesunate-Amodiaquine

  2019cites this paper
• Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo.

  2019cites this paper
• Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children

  2019cites this paper
• 11 The Pharmacogenetics of the Antimalarial Amodiaquine

  2018cites this paper
• Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety

  2018cites this paper
• Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment

  2016cites this paper
• Antimalarial metabolization: what have we learnt so far?

  2015cites this paper
• A High Force of Plasmodium vivax Blood-Stage Infection Drives the Rapid Acquisition of Immunity in Papua New Guinean Children

  2013cites this paper
• Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children

  2013cites this paper
• Therapeutic Efficacy of Artesunate–Amodiaquine Combinations and the Plasma and Saliva Concentrations of Desethylamodiaquine in Children With Acute Uncomplicated Plasmodium falciparum Malaria

  2013cites this paper
• The Pharmacogenetics of the Antimalarial Amodiaquine

  2012cites this paper
• Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after Pregnancy

  2012cites this paper
• Pharmacokinetics of Amodiaquine after a Single Oral Dose in Ghanaian Children with Uncomplicated Malaria

  2011cites this paper
• PHARMACEUTICAL EQUIVALENCE AND COMPARATIVE BIOAVAILABILITY OF MULTISOURCED ARTESUNATE AND AMODIAQUINE TABLETS IN SOUTH WESTERN NIGERIA

  2011cites this paper
• Development, Evaluation, and Application of an In Silico Model for Antimalarial Drug Treatment and Failure

  2011cites this paper
• The pharmacogenetics of antimalaria artemisinin combination therapy

  2011cites this paper
• Amodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose.

  2010cites this paper
• Pharmacokinetic Investigations of Oral Amodiaquine in Ghanaian Children: A Case Study of Suntreso Government Hospital, Kumasi.

  2009cites this paper
• Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination

  2009cites this paper
• Open label randomized comparison of dihydroartemisinin–piperaquine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam

  2009cites this paper
• Population pharmacokinetics of artesunate and amodiaquine in African children

  2009cites this paper
• Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy

  2009cites this paper
• Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers

  2009cites this paper
• Malaria: eficacia de amodiaquina-sulfadoxina-pirimetamina, estado nutricional y variantes alélicas del gen CYP2C8

  2009cites this paper
• Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance

  2008cites this paper
• Antimalarial dosing regimens and drug resistance.

  2008cites this paper
• Effect of Concomitant Artesunate Administration and Cytochrome P4502C8 Polymorphisms on the Pharmacokinetics of Amodiaquine in Ghanaian Children with Uncomplicated Malaria

  2008cites this paper
• Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers

  2008cites this paper
• Amodiaquine pharmacogenetics.

  2008cites this paper
• Determination of N-desethylamodiaquine by hydrophilic interaction liquid chromatography with tandem mass spectrometry: application to in vitro drug metabolism studies.

  2008cites this paper
• PHARMACOKINETICS AND DISPOSITION Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers

  2008cites this paper
• Artemisinin-based combination treatment of falciparum malaria.

  2007cites this paper
• Molecular determinants of the response to malaria therapeutics

  2007influential citation
• Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria

  2007influential citation
• CYTOCHROME P450 2C8 REACTION PHENOTYPING: SUBSTRATE SELECTION AND INHIBITION PROFILE

  2007cites this paper
• Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine.

  2007cites this paper
• Effects of Prior Administration of Amodiaquine on the Disposition of Halofantrine in Healthy Volunteers

  2007cites this paper
• Polymorphisms in the pfcrt and pfmdr 1 Genes of Plasmodium falciparum and in Vitro Susceptibility to Amodiaquine and Desethylamodiaquine

  2007cites this paper
• CYP2C8 and antimalaria drug efficacy

  2007influential citation
• World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology

  2007cites this paper
• Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea

  2006influential citation
• Pharmacogenetics of cytochromes P450 in tropical medicine.

  2006cites this paper
• Moving about.

  2005cites this paper